Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (241-250 of 264) with videos related to

Pageof 27
Sort By:
Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Egastroenterology|March 24, 2025
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver diseaseArmando Andres Roca Suarez, Frank Jühling, Julien Moehlin, et al.
Cell|August 14, 2018
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear ImportVeronica Rodriguez-Bravo, Raffaella Pippa, Won-Min Song, et al.
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
Science Translational Medicine|June 3, 2026
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma modelsZeina Nehme, Marion Muller, Jade Brochon, et al.
Hepatology (Baltimore, Md.)|September 7, 2017
A research agenda for curing chronic hepatitis B virus infectionHarvey Alter, Timothy Block, Nathaniel Brown, et al.
Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2026
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic RegionsHidenori Toyoda, Yujin Hoshida, Neehar D Parikh, et al.
Cancer Research|September 5, 2019
Recent Developments and Therapeutic Strategies against Hepatocellular CarcinomaMark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
Pageof 27

Showing results (241-250 of 264) with videos related to

Sort By:
Pageof 27
Gut|March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinomaFrank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Egastroenterology|March 24, 2025
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver diseaseArmando Andres Roca Suarez, Frank Jühling, Julien Moehlin, et al.
Cell|August 14, 2018
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear ImportVeronica Rodriguez-Bravo, Raffaella Pippa, Won-Min Song, et al.
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
Science Translational Medicine|June 3, 2026
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma modelsZeina Nehme, Marion Muller, Jade Brochon, et al.
Hepatology (Baltimore, Md.)|September 7, 2017
A research agenda for curing chronic hepatitis B virus infectionHarvey Alter, Timothy Block, Nathaniel Brown, et al.
Gastroenterology|March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic ResponseNourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2026
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic RegionsHidenori Toyoda, Yujin Hoshida, Neehar D Parikh, et al.
Cancer Research|September 5, 2019
Recent Developments and Therapeutic Strategies against Hepatocellular CarcinomaMark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
Pageof 27